|
|
methylation dependent chromatin silencing
|
GO:0006346 |
3 |
0.915
|
|
|
|
atp dependent chromatin remodeling
|
GO:0043044 |
25 |
0.730
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.633
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.481
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.480
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.454
|
Mouse |
|
|
positive regulation of protein autoubiquitination
|
GO:1902499 |
2 |
0.422
|
Human |
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.391
|
Human |
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.389
|
|
|
|
regulation of protein autoubiquitination
|
GO:1902498 |
3 |
0.346
|
Human |
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.331
|
Mouse |
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.276
|
Human |
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.262
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.254
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.248
|
|
|
|
macromolecule methylation
|
GO:0043414 |
97 |
0.244
|
Mouse |
|
|
histone methylation
|
GO:0016571 |
60 |
0.243
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.237
|
Human |
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.235
|
|
|
|
methylation
|
GO:0032259 |
106 |
0.235
|
Mouse |
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.223
|
Human |
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.219
|
Human |
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.217
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.215
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.211
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.205
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.202
|
|
|
|
protein autoubiquitination
|
GO:0051865 |
37 |
0.195
|
Human |
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.190
|
Human |
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.186
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.184
|
Human |
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.183
|
Human |
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.180
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
101 |
0.177
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.177
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
158 |
0.172
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.172
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.170
|
Human |
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.167
|
|
|
|
chromatin remodeling
|
GO:0006338 |
55 |
0.166
|
|
|
|
response to genistein
|
GO:0033595 |
1 |
0.162
|
|
|
|
embryonic digestive tract morphogenesis
|
GO:0048557 |
2 |
0.156
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.156
|
Mouse |
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.144
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.137
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.136
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.132
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.132
|
Human |
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.131
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.129
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.128
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.122
|
Human |
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.117
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.116
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.115
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.114
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.113
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.113
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.107
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.104
|
|
|
|
protein alkylation
|
GO:0008213 |
74 |
0.103
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.103
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.102
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.100
|
|
|
|
histone acetylation
|
GO:0016573 |
93 |
0.100
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.100
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.099
|
|
|
|
protein methylation
|
GO:0006479 |
74 |
0.098
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.097
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.096
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.093
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.092
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.092
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.088
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.086
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.086
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.085
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.084
|
Human |
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.084
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.083
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.083
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.082
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.080
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.080
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
4 |
0.079
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.079
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.079
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.077
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.076
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.075
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.075
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.074
|
|
|
|
regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033143 |
32 |
0.074
|
|
|
|
centrosome organization
|
GO:0051297 |
58 |
0.074
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.073
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.073
|
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
73 |
0.072
|
Human Mouse |
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.072
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.072
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.069
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.067
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.067
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.065
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.064
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.064
|
|
|
|
circadian behavior
|
GO:0048512 |
2 |
0.064
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
97 |
0.063
|
|
|
|
microtubule organizing center organization
|
GO:0031023 |
62 |
0.063
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.063
|
|
|
|
regulation of transcription involved in cell fate commitment
|
GO:0060850 |
6 |
0.063
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.062
|
|
|
|
epidermis development
|
GO:0008544 |
59 |
0.062
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.062
|
Zebrafish |
|
|
response to bacterium
|
GO:0009617 |
144 |
0.062
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.060
|
|
|
|
negative regulation of axonogenesis
|
GO:0050771 |
4 |
0.060
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.060
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.060
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.060
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.059
|
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.058
|
|
|
|
tricarboxylic acid metabolic process
|
GO:0072350 |
4 |
0.057
|
|
|
|
nucleosome positioning
|
GO:0016584 |
3 |
0.056
|
|
|
|
rna interference
|
GO:0016246 |
4 |
0.056
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.055
|
|
|
|
post embryonic organ development
|
GO:0048569 |
1 |
0.054
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.053
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.053
|
|
|
|
pituitary gland development
|
GO:0021983 |
2 |
0.052
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.052
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.051
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.051
|
|
|
|
positive regulation of gliogenesis
|
GO:0014015 |
4 |
0.051
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.050
|
|
|
|
system process
|
GO:0003008 |
349 |
0.050
|
|
|
|
regulation of g2 m transition of mitotic cell cycle
|
GO:0010389 |
20 |
0.050
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.050
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.049
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.049
|
|
|
|
melanin metabolic process
|
GO:0006582 |
1 |
0.049
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.048
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.048
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.047
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.047
|
|
|
|
atp catabolic process
|
GO:0006200 |
157 |
0.047
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.046
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
159 |
0.046
|
|
|
|
growth
|
GO:0040007 |
202 |
0.045
|
Zebrafish |
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.045
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.045
|
Zebrafish |
|
|
citrate metabolic process
|
GO:0006101 |
2 |
0.045
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.043
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.043
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.043
|
Human |
|
|
membrane organization
|
GO:0061024 |
292 |
0.043
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.043
|
Zebrafish |
|
|
tube development
|
GO:0035295 |
125 |
0.042
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.041
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.041
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
2 |
0.041
|
|
|
|
tongue development
|
GO:0043586 |
1 |
0.041
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.041
|
|
|
|
rostrocaudal neural tube patterning
|
GO:0021903 |
1 |
0.041
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.040
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.040
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.040
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.040
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.040
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.039
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.039
|
|
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
4 |
0.038
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.038
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.038
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.038
|
Human |
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.038
|
Human |
|
|
positive regulation of vascular endothelial growth factor signaling pathway
|
GO:1900748 |
3 |
0.038
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.037
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.037
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.037
|
|
|
|
double strand break repair
|
GO:0006302 |
101 |
0.036
|
Human |
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.036
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.036
|
|
|
|
protein acetylation
|
GO:0006473 |
116 |
0.036
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.036
|
|
|
|
natural killer cell differentiation
|
GO:0001779 |
2 |
0.036
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.036
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.036
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.036
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.035
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.035
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.035
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.035
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.034
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.034
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.034
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.034
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.034
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.034
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.034
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.034
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.033
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
61 |
0.033
|
Human |
|
|
cell division
|
GO:0051301 |
168 |
0.033
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.033
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
101 |
0.032
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.032
|
Zebrafish |
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.032
|
|
|
|
lactation
|
GO:0007595 |
3 |
0.032
|
|
|
|
response to uv
|
GO:0009411 |
73 |
0.032
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.032
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.032
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.031
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.031
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.031
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.031
|
|
|
|
nucleosome organization
|
GO:0034728 |
66 |
0.031
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.031
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.030
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.030
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.030
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
3 |
0.030
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.030
|
Human |
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.030
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.030
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.030
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.030
|
|
|
|
bmp signaling pathway involved in heart development
|
GO:0061312 |
3 |
0.029
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.029
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.029
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.029
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.029
|
|
|
|
head development
|
GO:0060322 |
108 |
0.029
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.029
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.029
|
|
|
|
detection of chemical stimulus involved in sensory perception of smell
|
GO:0050911 |
2 |
0.029
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
65 |
0.029
|
Human |
|
|
metencephalon development
|
GO:0022037 |
2 |
0.029
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.028
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.028
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.028
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.028
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.028
|
|
|
|
melanocyte differentiation
|
GO:0030318 |
2 |
0.028
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.028
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
72 |
0.028
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.028
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.028
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.028
|
|
|
|
positive regulation of glucocorticoid receptor signaling pathway
|
GO:2000324 |
1 |
0.027
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.027
|
|
|
|
regulation of chemokine production
|
GO:0032642 |
31 |
0.027
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.027
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.027
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.027
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.027
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.027
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
3 |
0.027
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.027
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.026
|
|
|
|
autophagic cell death
|
GO:0048102 |
3 |
0.026
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.026
|
|
|
|
actin filament based movement
|
GO:0030048 |
17 |
0.026
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.026
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
42 |
0.026
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.026
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
2 |
0.025
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
3 |
0.025
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
108 |
0.025
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.025
|
|
|
|
histone demethylation
|
GO:0016577 |
15 |
0.025
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.025
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.025
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.025
|
|
|
|
eyelid development in camera type eye
|
GO:0061029 |
2 |
0.025
|
|
|
|
heart formation
|
GO:0060914 |
2 |
0.025
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
60 |
0.024
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.024
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.024
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.024
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.024
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
70 |
0.024
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.024
|
|
|
|
negative regulation of nf kappab transcription factor activity
|
GO:0032088 |
51 |
0.024
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.024
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.023
|
|
|
|
rna splicing
|
GO:0008380 |
131 |
0.023
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.023
|
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.023
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
4 |
0.023
|
|
|
|
cerebellum development
|
GO:0021549 |
2 |
0.023
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.023
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.023
|
|
|
|
vitamin d receptor signaling pathway
|
GO:0070561 |
4 |
0.023
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.023
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.023
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.023
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.023
|
|
|
|
regulation of behavior
|
GO:0050795 |
82 |
0.023
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.023
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.023
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.022
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.022
|
|
|
|
histone lysine demethylation
|
GO:0070076 |
14 |
0.022
|
|
|
|
pharyngeal system development
|
GO:0060037 |
2 |
0.022
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.022
|
|
|
|
cell projection assembly
|
GO:0030031 |
126 |
0.022
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.022
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.022
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.022
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.022
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.022
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.022
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.022
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.021
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.021
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.021
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.021
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.021
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.021
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.021
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
69 |
0.021
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
3 |
0.021
|
|
|
|
regulation of methylation dependent chromatin silencing
|
GO:0090308 |
3 |
0.021
|
|
|
|
cell junction organization
|
GO:0034330 |
79 |
0.021
|
|
|
|
memory
|
GO:0007613 |
3 |
0.021
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.021
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.020
|
|
|
|
negative regulation of reactive oxygen species metabolic process
|
GO:2000378 |
11 |
0.020
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.020
|
|
|
|
neural tube patterning
|
GO:0021532 |
2 |
0.020
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
82 |
0.020
|
|
|
|
urea metabolic process
|
GO:0019627 |
3 |
0.020
|
|
|
|
cellular heat acclimation
|
GO:0070370 |
3 |
0.020
|
|
|
|
reproductive system development
|
GO:0061458 |
56 |
0.020
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.020
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.020
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.020
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.020
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.020
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.020
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.020
|
|
|
|
neural tube closure
|
GO:0001843 |
3 |
0.020
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.020
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.020
|
|
|
|
demethylation
|
GO:0070988 |
37 |
0.020
|
|
|
|
somatic muscle development
|
GO:0007525 |
1 |
0.020
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
119 |
0.020
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.019
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.019
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.019
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
48 |
0.019
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.019
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.019
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.019
|
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.019
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.019
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
19 |
0.019
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.019
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.019
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.019
|
|
|
|
protein dealkylation
|
GO:0008214 |
17 |
0.019
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.019
|
|
|
|
determination of dorsal ventral asymmetry
|
GO:0048262 |
4 |
0.019
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.019
|
Human |
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.018
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
119 |
0.018
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
3 |
0.018
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
3 |
0.018
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
1 |
0.018
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.018
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.018
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.018
|
|
|
|
cell fate commitment
|
GO:0045165 |
27 |
0.018
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.018
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.018
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.018
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.018
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.018
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.018
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.018
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.018
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.018
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.018
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.017
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
71 |
0.017
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.017
|
|
|
|
negative regulation of posttranscriptional gene silencing
|
GO:0060149 |
3 |
0.017
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.017
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.017
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.017
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
85 |
0.017
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
19 |
0.017
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.017
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.017
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.017
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.017
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
117 |
0.017
|
|
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.016
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.016
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.016
|
|
|
|
single organism nuclear import
|
GO:1902593 |
104 |
0.016
|
|
|
|
actin filament organization
|
GO:0007015 |
128 |
0.016
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.016
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
3 |
0.016
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.016
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
43 |
0.016
|
|
|
|
defense response to bacterium
|
GO:0042742 |
63 |
0.016
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.016
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.016
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.016
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.016
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.016
|
|
|
|
spinal cord development
|
GO:0021510 |
4 |
0.016
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.016
|
|
|
|
embryonic hindlimb morphogenesis
|
GO:0035116 |
2 |
0.016
|
|
|
|
protein targeting to membrane
|
GO:0006612 |
42 |
0.016
|
|
|
|
axis elongation
|
GO:0003401 |
4 |
0.016
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.016
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.016
|
|
|
|
chromatin silencing
|
GO:0006342 |
12 |
0.016
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
39 |
0.016
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.016
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.016
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.016
|
|
|
|
pancreatic a cell differentiation
|
GO:0003310 |
1 |
0.016
|
|
|
|
secretory granule organization
|
GO:0033363 |
2 |
0.016
|
|
|
|
gene silencing
|
GO:0016458 |
49 |
0.016
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.015
|
|
|
|
heart field specification
|
GO:0003128 |
2 |
0.015
|
|
|
|
cell junction assembly
|
GO:0034329 |
67 |
0.015
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.015
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.015
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
69 |
0.015
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.015
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.015
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.015
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.015
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.015
|
|
|
|
chromatin assembly
|
GO:0031497 |
61 |
0.015
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
1 |
0.015
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.015
|
|
|
|
long term memory
|
GO:0007616 |
2 |
0.015
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.015
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.015
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.015
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.015
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.015
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.015
|
|
|
|
regulation of defense response to virus
|
GO:0050688 |
33 |
0.015
|
|
|
|
intracellular estrogen receptor signaling pathway
|
GO:0030520 |
23 |
0.015
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
56 |
0.015
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.015
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.015
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.015
|
|
|
|
response to cocaine
|
GO:0042220 |
1 |
0.015
|
|
|
|
ectodermal placode formation
|
GO:0060788 |
1 |
0.015
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.015
|
|
|
|
positive regulation of dna metabolic process
|
GO:0051054 |
73 |
0.014
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.014
|
|
|
|
muscle system process
|
GO:0003012 |
81 |
0.014
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
4 |
0.014
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.014
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.014
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.014
|
|
|
|
myoblast fusion
|
GO:0007520 |
1 |
0.014
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.014
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.014
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
2 |
0.014
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.014
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
128 |
0.014
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.014
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
4 |
0.014
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
24 |
0.014
|
|
|
|
vesicle organization
|
GO:0016050 |
62 |
0.014
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.014
|
|
|
|
regulation of cell cycle g2 m phase transition
|
GO:1902749 |
22 |
0.014
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.014
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.014
|
|
|
|
response to interferon gamma
|
GO:0034341 |
39 |
0.014
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.014
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
104 |
0.014
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
2 |
0.014
|
|
|
|
protein folding
|
GO:0006457 |
38 |
0.014
|
|
